Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus

Nonalcoholic fatty liver disease (NAFLD) is believed to be the most common chronic liver disease, affecting at least one-third of the population worldwide. The more aggressive form is known as nonalcoholic steatohepatitis (NASH) and characterized by hepatocyte necrosis and inflammation. The presence...

Descripción completa

Detalles Bibliográficos
Autores principales: Portillo-Sanchez, Paola, Cusi, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471954/
https://www.ncbi.nlm.nih.gov/pubmed/28702244
http://dx.doi.org/10.1186/s40842-016-0027-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471954/
https://www.ncbi.nlm.nih.gov/pubmed/28702244
http://dx.doi.org/10.1186/s40842-016-0027-7

Ejemplares similares